The Use of Steovess/Binosto After Denosumab Discontinuation to Prevent Increase in Bone Turnover
Condition(s):Erosive OsteoarthritisLast Updated:April 22, 2022Completed
Hide Studies Not Open or Pending
Condition(s):Erosive OsteoarthritisLast Updated:April 22, 2022Completed
Condition(s):Osteoporosis, Osteopenia; Renal Transplant RecipientLast Updated:November 12, 2021Completed
Condition(s):OsteoporosisLast Updated:February 3, 2022Completed
Condition(s):Heart Transplantation; Liver Transplantation; Bone ResorptionLast Updated:August 16, 2018Completed
Condition(s):Osteogenesis ImperfectaLast Updated:December 10, 2014Completed
Condition(s):AsthmaLast Updated:January 12, 2018Completed
Condition(s):OsteoporosisLast Updated:November 7, 2010Completed
Condition(s):Spinal Cord Injury; OsteoporosisLast Updated:January 29, 2016Terminated
Condition(s):Intrabony Periodontal DefectLast Updated:June 10, 2016Completed
Condition(s):Knee OsteoarthritisLast Updated:April 22, 2022Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.